Codiak Biosciences

Developer of exosome-based drugs and diagnostics for cancer treatment

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups48 employees language codiakbio.com

Registered entities

Investor mix

12 investors on record; lead investors include Arch Venture Partners, Flagship Pioneering.

Investor typeCountShare
Venture capital542%
Private equity217%
Other / undisclosed542%
Coming soon